Showing results (141-150 of 764) with videos related to
Sort By:
Pageof 77
Histopathology|October 31, 2025
Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrenceNancy Y Greenland, Janet E Cowan, Chien-Kuang Cornelia Ding, et al.European Urology Oncology|July 6, 2025
The Natural History of Confirmed Grade Group 1 Prostate Cancer Managed with Active Surveillance in the Modern EraKevin Shee, Jonathan J Song, Janet E Cowan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Outcomes of active surveillance for men with intermediate-risk prostate cancerMatthew R Cooperberg, Janet E Cowan, Joan F Hilton, et al.Current Urology Reports|March 28, 2013
Risk-based prostate cancer screening: who and how?Allison S Glass, K Clint Cary, Matthew R CooperbergCurrent Opinion in Urology|November 19, 2014
Diagnostic associations of gene expression signatures in prostate cancer tissueHao G Nguyen, Christopher J Welty, Matthew R CooperbergEuropean Urology Focus|August 3, 2025
Determining Optimal Patient Selection for High-intensity Focused Ultrasound for Prostate CancerKevin Shee, William A Pace, Andrew W Liu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 6, 2013
Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohortMatthew R Cooperberg, Jeffry P Simko, Janet E Cowan, et al.Urologic Oncology|July 5, 2023
Long-term complications and health-related quality of life outcomes after radical prostatectomy with or without subsequent radiation treatment for prostate cancerAvi Baskin, Janet E Cowan, Avery Braun, et al.Japanese Journal of Clinical Oncology|January 6, 2012
Fifth Joint Meeting of J-CaP and CaPSURE: advancing the global understanding of prostate cancer and its managementHideyuki Akaza, Peter Carroll, Matthew R Cooperberg, et al.The Journal of Urology|November 13, 2004
The impact of patient advocacy: the University of California-San Francisco experiencePeter R Carroll, Pageof 77